- Home
- FBP vs AXNX Comparison
FBP vs AXNX Comparison
Compare FBP & AXNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBP
- AXNX
- Stock Information
- Founded
- FBP 1948
- AXNX 2012
- Country
- FBP United States
- AXNX United States
- Employees
- FBP N/A
- AXNX N/A
- Industry
- FBP Major Banks
- AXNX Medical/Dental Instruments
- Sector
- FBP Finance
- AXNX Health Care
- Exchange
- FBP Nasdaq
- AXNX Nasdaq
- Market Cap
- FBP 3.4B
- AXNX 3.6B
- IPO Year
- FBP N/A
- AXNX N/A
- Fundamental
- Price
- FBP $21.03
- AXNX N/A
- Analyst Decision
- FBP Buy
- AXNX Hold
- Analyst Count
- FBP 4
- AXNX 8
- Target Price
- FBP $20.75
- AXNX $71.00
- AVG Volume (30 Days)
- FBP 1.1M
- AXNX 571.3K
- Earning Date
- FBP 10-23-2024
- AXNX 11-07-2024
- Dividend Yield
- FBP 3.03%
- AXNX N/A
- EPS Growth
- FBP 9.82
- AXNX N/A
- EPS
- FBP 1.81
- AXNX N/A
- Revenue
- FBP $868,818,000.00
- AXNX $431,902,000.00
- Revenue This Year
- FBP N/A
- AXNX $25.35
- Revenue Next Year
- FBP $5.15
- AXNX $19.92
- P/E Ratio
- FBP $11.66
- AXNX N/A
- Revenue Growth
- FBP N/A
- AXNX 26.08
- 52 Week Low
- FBP $14.72
- AXNX $55.09
- 52 Week High
- FBP $22.40
- AXNX $71.05
- Technical
- Relative Strength Index (RSI)
- FBP 54.30
- AXNX 1.26
- Support Level
- FBP $20.34
- AXNX $70.37
- Resistance Level
- FBP $22.15
- AXNX $71.05
- Average True Range (ATR)
- FBP 0.61
- AXNX 0.15
- MACD
- FBP 0.02
- AXNX -8.31
- Stochastic Oscillator
- FBP 61.19
- AXNX 0.00
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About AXNX Axonics Inc.
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.